COVID-19 UPDATES AND RESOURCES
ALLIANCE FOUNDATION TRIALS
Updated 06 MAY 21
Guidance for sites that participate in remote monitoring activities during the COVID-19 Pandemic.
Updated 01 APR 21
Guidance for investigative sites that do not have a policy in place for remote re-consent of subjects. Unless extended, this guidance is only valid until 01 SEP 21.
Updated 25 Jan 21
Notification and guidance regarding use of COVID-19 vaccine for AFT trials.
Updated 23 SEP 20
Information to ensure all AFT sites continue to provide vital health information to AFT for safety monitoring and reporting of enrolled participants.
Updated 22 APR 20
Notifcation updated to include remote re-consenting of study participants.
AFT SDC AT MAYO
Updated 04 JUN 20
Explanation of the new form in RAVE for each AFT study, including guidelines and related information.
Instructions due to limited operations of the AFT Biospecimen Repository and other biospecimen repositories.
AFT BIOREPOSITORY (AFT BioMS)
Please review this website directly to view up to date information as the biorepository institutes changes in services and new communications.
Updated 04 AUG 20
Update on services and shipments from our biorepository. For the most up to date information, please go to the AFT Biorepository website, above.
Updated 19 MAR 20
Update on services and shipments from our biorepository and includes contact information for the AFT BioMS.